With global financial conditions leading to tough market conditions, investors are looking to de-risk their investments. This leads to higher and higher requirements which medtech start-ups need to meet in order to grow their business. To meet the necessary milestones, companies need to be smart, and sometimes creative with their financing strategy to traverse this capital-constrained market.

• Investor perspectives on the medtech landscape
• How are medtech companies diversifying revenue streams?
• Smart savings, strategies to meet milestones while still being economical
• How to prepare your company for an exit
  
  

Following the healthtech boom at the tailend of the COVID-19 pandemic, growth within the sector has slowed and capital has become less available for healthtech startups. This means that companies need to be smarter with how they use their hard-earned investment, using investment for survival is not enough to grow a thriving business.

• How can healthtech companies strategically use invested capital to drive growth and meet milestones?
• When is the right time to start the next series of funding?
• Exploring strategies to limit burn rate and make investment go further